Glaukos Announces FDA 510(k) Clearance of iPRIME
This technology further expands Glaukos’ broad portfolio of innovative ophthalmic solutions and is consistent with our longstanding position…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
07 Jan 22
This technology further expands Glaukos’ broad portfolio of innovative ophthalmic solutions and is consistent with our longstanding position…
08 Dec 21
IOPerfect combines AI-based visual analysis in a VR-like headset to enable tele-diagnosis and remote monitoring of glaucoma
03 Dec 21
Acquisition of Katena will expand Corza's portfolio of ophthalmic surgery products, and adds value to its ophthalmic surgery…
01 Dec 21
The acquisition will allow NeoLight to enhance its newborn eye screening and hyperbilirubinemia detection/treatment product offerings through combined…
30 Nov 21
The presbyopia-correcting intraocular lens, with a fluid optic component, is designed for the permanent restoration of clear and…
23 Nov 21
SmartERG Platform is capable of collecting and analysing data on the smartphone of the user, under the guidance…
12 Nov 21
The acquisition will enable LumiThera to add a complementary diagnosis and monitoring platform to its treatment platform using…
09 Nov 21
The acquisition will enable Alcon to expand its portfolio across cataract, refractive, retina and glaucoma, in addition to…
25 Oct 21
Conducted at 15 sites in the US, the randomised, double-masked, multi-centre and vehicle-controlled clinical trial was conducted to…
21 Oct 21
The new digital therapeutic enables patients to watch therapeutically modified TV shows and movies to enhance their vision…